Posts

Showing posts from April, 2011

Aspirin's Clot-Prevention Ability Blunted by Dietary Fat

Image
Aspirin 's ability to prevent potentially deadly blood clots may be hindered by elevated levels of fatty acids in the bloodstream, a new study suggests. It's common for doctors to prescribe aspirin as a blood thinner for patients at high risk of a heart attack. Aspirin inhibits the activity of the COX-1 enzyme, which plays a role in blood clot formation. It's known that free fatty acids -- released into the bloodstream during the breakdown of fat cells -- also inhibit COX-1 activity.

Symptoms in the Pharmacy :Gastrointestinal Tract Problems(15)

Diarrhoea: Treatment timescale One day in children, otherwise 2 days. Management Oral rehydration therapy The risk of dehydration from diarrhoea is greatest in babies, and rehydration therapy is considered to be the standard treatment for acute diarrhoea in babies and young children.

FDA Approves Duexis

Image
The U.S. Food and Drug Administration (FDA) has approved Duexis (ibuprofen/famotidine), a novel tablet formulation containing a fixed-dose combination of ibuprofen (800 mg) and famotidine (26.6 mg). The FDA approval was supported by data from the pivotal REDUCE-1 and REDUCE-2 studies, which showed patients taking Duexis experienced significantly fewer upper gastrointestinal ulcers compared to patients receiving ibuprofen alone.